Kaplan USMLE Step 2 prep: Man has worsening symptoms


If you’re preparing for the United States Medical Licensing Examination® (USMLE®) Step 2 exam, you might want to know which questions are most often missed by test-prep takers. Check out this example from Kaplan Medical, and read an expert explanation of the answer. Also check out all posts in this series.  

Students save with AMA membership

  • $68 for a four-year membership–only $17 per year
  • Unlimited access to the JAMA Network®

Supporting you today as a medical student. Protecting your future as a physician.

The AMA and Kaplan have teamed up to support you in reaching your goal of passing the USMLE® or COMLEX-USA®. If you're looking for additional resources, Kaplan provides free access to tools for pre-clinical studies, including Kaplan’s Lecture Notes series, Integrated Vignettes, Shelf Prep and more​​​​​​​.

A 32-year-old man comes to his physician with one year of worsening nausea, abdominal pain, constipation, diffuse bone pain, and intermittent headaches. The patient has a 10 pack-year history of smoking and denies use of alcohol or recreational drugs. His blood pressure is 130/80 mm Hg, pulse 90 per minute, respirations 18 per minute, temperature 37ordmC (98.6ordmF). The exam shows dry mucous membranes and mild left lower quadrant abdominal pain on deep palpation. CBC/Serum lab studies show:

WBC: 7,000 mm3

Hemoglobin: 14 g/dL

Hematocrit: 50%

Platelets: 250,000 mm3

Na+: 145 mEq/L

K+: 5.0 mEq/L

Cl-: 100 mEq/L

HCO3- : 24 mEq/L

BUN: 30 mg/dL

Creatinine: 1.0 mg/dL

Glucose: 100 mg/dL

Albumin: 4 g/dL

Phosphate: 3.0 mg/dL

PTH: 60 pg/dL (N= 11 - 54 pg/dL)

The chest X-ray is normal. What is the most appropriate next step in the management of this patient's current condition?

A. MRI of the thyroid/parathyroid gland.

B. PTH-related protein measurement.

C. Sestamibi scan of the neck.

D. Urinary calcium level.

E. Vitamin D level.

Related Coverage

Kaplan USMLE Step 2 prep: 6 stumpers involving senior patients










The correct answer is D.

This patient has the classic symptoms of hypercalcemia: abdominal pain, bone pain, constipation, and headaches. Hypercalcemia may be due to hyperparathyroidism, benign familial hypocalciuric hypercalcemia (FHH), malignancy (due to PTH-related protein), or elevated Vitamin D levels due to ingestion or granulomatous diseases.

The first step in workup is a parathyroid hormone level, elevated in this case. The most common cause of hypercalcemia in the general population is primary hyperparathyroidism. The two most common causes of PTH-dependent hypercalcemia are primary hyperparathyroidism and FHH. FHH is the genetic lack of the calcium-sensing receptor on the parathyroid gland and in the kidney, leading to elevated PTH (and consequent hypercalcemia) with low renal calcium excretion.

Related coverage

Studying for the USMLE or COMLEX-USA tests

In contrast, in primary hyperparathyroidism the renal calcium excretion is elevated, as it is in most hypercalcemic patients. Therefore, a way to differentiate the two conditions is to obtain a urinary calcium level; a low urinary calcium level and a positive family history will point toward the diagnosis of FHH, while an elevated urine calcium suggests primary hyperparathyroidism.

Choice A: CT and MRI of the thyroid/parathyroid are options for presurgical evaluation of the parathyroids, but should not be done before the urine calcium, in order to avoid unnecessary testing.

Choice B: PTH-related protein measurement should be drawn when malignancy is considered to be the cause of the hypercalcemia. Besides his 10 pack-year smoking history, this patient is young, has a normal chest X ray, and malignancy is not evident in this case. Squamous cell carcinomas are most associated with this paraneoplastic syndrome.

Choice C: Nuclear Sestamibi scan of the neck is used to preoperatively localize a parathyroid adenoma in primary hyperparathyroidism. It would be appropriate in a patient whose urinary calcium is elevated, but not before doing the urine calcium to exclude FHH.

Choice E: Vitamin D is a fat-soluble vitamin that, in excess, is associated with hypercalcemia. This may be due to dietary ingestion or to some malignant and granulomatous diseases that produce Vitamin D. Hypercalcemia secondary to elevated vitamin D toxicity would cause a non-PTH dependent hypercalcemia; on labs, this would show a low PTH and a high serum phosphorous level. This patient has an elevated PTH level; therefore, the patient's condition must result from one of the PTH-dependent causes.

Symptoms of hypercalcemia include bone pain, recurrent kidney stones, and headaches.

The most common cause of hypercalcemia is primary hyperparathyroidism.

The first diagnostic test for hypercalcemia is a serum PTH level; if elevated, a urine calcium level should be done to exclude familial hypocalciuric hyperparathyroidism.